Bristol Myers Squibb Drug Zenbexus Cuts Blood Cancer Progression Risk by 51 Percent in Phase 3 Trial
Bristol Myers Squibb announced that its drug Zenbexus cut multiple myeloma progression risk by 51%, offering a new oral option for blood cancer.
Company news
Every story explained in plain English, with the prices that matter beside it.
SIFCO Industries Shares Surge Over 300% Year to Date on Strong Defense Demand
SIFCO Industries stock has surged nearly 310% this year, driven by rising military demand and strategic debt reduction despite recent quarterly losses.
ServiceNow Faces Valuation and Margin Pressure Despite Rapid Growth in Agentic AI
ServiceNow shares face pressure from high valuation and acquisition costs, even as the company sees rapid growth in its Agentic AI products.
Advanced Energy Industries Shares Rise 40 Percent YTD on Strong Semiconductor and Data Center Demand
Advanced Energy Industries shares have gained nearly 40% this year, driven by soaring demand for semiconductor and AI data center power solutions.
Waymo Secures $5 Billion in First External Debt Funding Round
Waymo has raised $5 billion in external debt to fund its autonomous vehicle expansion, marking a shift away from sole reliance on parent company Alphabet.
Phibro Animal Health Moves Forward on Zoetis Acquisition and Vaccine Growth
Phibro Animal Health sees revenue gains from its Zoetis acquisition and vaccine expansion, though rising costs and currency risks present challenges.
Palo Alto Networks Introduces AI-Powered Security Subscription Service
Palo Alto Networks launched an AI security subscription service to continuously find and fix client vulnerabilities.
CVS Health Shares Trade at a Discount to Industry Peers Despite Strong Segment Performance
CVS Health Corporation trades at a lower valuation than its industry peers despite raising its operating income outlook and recovering insurance margins.
Upstart Holdings Expands Credit Union Network With Denver Partnership
Upstart Holdings partners with Credit Union of Denver to expand its AI-powered lending network and boost loan accessibility.
VICI Properties Trades at Lower Valuation Multiple Than Real Estate Peers
VICI Properties shares trade at a lower earnings multiple than industry peers despite steady occupancy and a long-term lease portfolio.
Micron Stock Pulls Back on Tech Sector Weakness Despite Bullish AI Outlook
Micron Technology shares fell amid a broader tech sector decline, even as analysts predict long-term growth driven by artificial intelligence.
Biohaven Partners With Ono Pharmaceutical in 100 Million Dollar Asian Licensing Deal
Biohaven Ltd. partnered with Ono Pharmaceutical to license its autoimmune drug portfolio in Asia, securing up to 100 million dollars in near-term payments.
PPG Industries Boosts First-Half Operating Cash Flow to $594 Million on Cost Savings
PPG Industries generated 594 million dollars in operating cash flow during the first half of 2026, driven by cost-cutting and price increases.
FanDuel Outpaces DraftKings in Early NFL Season Engagement
FanDuel is capturing sports betting share from DraftKings early in the NFL season as promotional programs drive user engagement and activity.
Landsbankinn hf. Sells ISK 1.1 Billion in Covered Bonds at 7.68% Yield
Landsbankinn hf. raised ISK 1.1 billion through a routine covered bond sale to secure funding at a 7.68% yield.
Company newsNeutral
bioAffinity Technologies to Raise $4 Million in Direct Offering to Fund Lung Cancer Test Sales
bioAffinity Technologies is raising $4 million in a direct stock offering to fund the commercial growth of its noninvasive lung cancer test, CyPath Lung.
bioAffinity Technologies Raises 4 Million Dollars in Stock and Warrant Offering
bioAffinity Technologies is raising approximately 4 million dollars to fund working capital and commercialization efforts for its CyPath Lung test.
ServiceTitan Shares Rise as Analysts Highlight Artificial Intelligence Growth Potential
ServiceTitan shares climbed after analysts expressed optimism about the company's new artificial intelligence tools and platform expansions.
JPMorgan Chase Crosses Voting Rights Threshold in NORMA Group
JPMorgan Chase & Co. crossed a major voting rights threshold in NORMA Group SE, signaling a shift in institutional positioning as the stock declines.
Oscar Health Eyes Expansion Amid ACA Concentration Risks and Valuation Concerns
Oscar Health shares have surged 130.3% this year, but high reliance on the ACA marketplace and an expensive valuation present key risks for investors.